Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New Study Demonstrates That Xangold® Natural Lutein Ester Supplements May Benefit Those With Early Stage Macular Degeneration
- New Study Demonstrates That Xangold® Natural Lutein Ester Supplements May Benefit Those With Early Stage Macular Degeneration
- Chrysantis(TM), Inc. Responds to Lutein, Zeaxanthin Study
Company reponds to interpretation of study results published in the Journal of Nutrition (135:1763-1769, July 2005) regarding lutein and zeaxanthin.
- Chrysantis(TM), Inc. Responds to Lutein, Zeaxanthin Study
Company reponds to interpretation of study results published in the Journal of Nutrition (135:1763-1769, July 2005) regarding lutein and zeaxanthin.
- Chrysantis(TM), Inc. Responds to Lutein, Zeaxanthin Study
Company reponds to interpretation of study results published in the Journal of Nutrition (135:1763-1769, July 2005) regarding lutein and zeaxanthin.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- Web Site Detailing Zeaxanthin Science Adds New Pola Group Study
Company presents comprehensive, easily accessible abstract collection is readily available on the web site www.Chrysantis.com. The most recent addition is the study conducted by the Ocular Pathologies Associated with Age group.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- Higher Dietary DHA/EPA Omega-3 Fatty Acids Associated with Lessened Progression in Age-related Vision Loss
Dr. J. P. SanGiovanni reported this afternoon, at the ISSFAL Congress in Cairns, Australia, on the relationship of dietary omega-3 intakes as DHA/EPA, found mainly in fish, to the deterioration in visual performance with aging.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Nationwide Study Will Evaluate Effect of Antioxidants and Fish Oil on Progression of Age-Related Macular Degeneration (AMD)
The National Institutes of Health (NIH) announces a nationwide study, Age-Related Eye Disease Study 2 (AREDS2), to see if a modified combination of vitamins, minerals, and fish oil can further slow the progression of vision loss from AMD, the leading cause of vision loss in the United States for people over age 60.
- New Study Shows Zeaxanthin and Lutein Supplements Imrove Night Vision and Visual Performance
Study appearing in Ophthalmic and Physiological Optics, The Journal of the College of Optometrists suggests that night vision can be improved by supplementing a diet with lutein and OPTISHARP(TM) brand zeaxanthin.
- New Study Shows Zeaxanthin and Lutein Supplements Imrove Night Vision and Visual Performance
Study appearing in Ophthalmic and Physiological Optics, The Journal of the College of Optometrists suggests that night vision can be improved by supplementing a diet with lutein and OPTISHARP(TM) brand zeaxanthin.
- New Study Shows Zeaxanthin and Lutein Supplements Imrove Night Vision and Visual Performance
Study appearing in Ophthalmic and Physiological Optics, The Journal of the College of Optometrists suggests that night vision can be improved by supplementing a diet with lutein and OPTISHARP(TM) brand zeaxanthin.
- Researchers study supplements to limit damage from macular degeneration
A team of investigators at Washington University School of Medicine in St. Louis and other centers around the United States is evaluating dietary supplements to determine if they can prevent some of the damage from age-related macular degeneration. Some patients also will receive certain omega-3 fatty acids that are contained in fish oils, and others will take supplements containing either lutein and zeaxanthin that normally are made in the retina.
- Researchers study supplements to limit damage from macular degeneration
A team of investigators at Washington University School of Medicine in St. Louis and other centers around the United States is evaluating dietary supplements to determine if they can prevent some of the damage from age-related macular degeneration. Some patients also will receive certain omega-3 fatty acids that are contained in fish oils, and others will take supplements containing either lutein and zeaxanthin that normally are made in the retina.
- Researchers study supplements to limit damage from macular degeneration
A team of investigators at Washington University School of Medicine in St. Louis and other centers around the United States is evaluating dietary supplements to determine if they can prevent some of the damage from age-related macular degeneration. Some patients also will receive certain omega-3 fatty acids that are contained in fish oils, and others will take supplements containing either lutein and zeaxanthin that normally are made in the retina.
- New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
- New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
- New study shows that a daily supplement of 12 mg lutein from Xangold(R) natural lutein esters increases macular pigment density in adults with early-stage AMD
Study published in the April edition of Experimental Eye Research involved 108 adults who received a daily supplement containing antioxidants - including 12 mg lutein from Xangold(R) lutein esters - for six months and a contro, groupo who recevied no supplements. Results in the intervention group showed substantial increases in blood levels of lutein and a statistically significant average increase of 16% in macular pigment density.
- Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
- Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
- Two new studies boost evidence for the bioavailability and efficacy of Xangold(R) natural lutein esters
In his presentation at the Vitafoods International Supplier Seminar Theatre today (Wednesday, May 9), Holger Becker, Ph.D., cited two new studies which strengthen existing scientific evidence on the bioavailability and efficacy of Xangoldâ natural lutein esters.
- Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
- Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
- Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
- Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
- Higher intake of fish and vitamin D levels linked to lower risk of age-related macular disease
Two reports in the May issue of Archives of Ophthalmology indicate that Individuals who have higher dietary intake of foods with omega-3 fatty acids and higher fish consumption have a reduced risk of advanced age-related macular degeneration, while those with higher serum levels of vitamin D may have a reduced risk of the early stages of the disease.
- Fatty acids beneficial in treatment for dry eye syndrome
Research conducted at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.
- Fatty acids beneficial in treatment for dry eye syndrome
Research conducted at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.
- Fatty acids beneficial in treatment for dry eye syndrome
Research conducted at the Schepens Eye Research Institute have found for the first time that topical drop application of alpha-linolenic acid (ALA) led to a significant decrease in clinical signs of dry eye syndrome (DES) in animal models.
- New Study: Mirtogenol(TM) Lowers High Intraocular Hypertension
New research published in the July issue of Molecular Vision demonstrates that natural supplement Mirtogenol(TM), a combination of standardized bilberry extract Mirtoselect® and French maritime pine bark extract Pycnogenol®, lowers high intraocular pressure (IOP), which significantly reduces the likelihood of developing glaucoma.
- New Study: Mirtogenol(TM) Lowers High Intraocular Hypertension
New research published in the July issue of Molecular Vision demonstrates that natural supplement Mirtogenol(TM), a combination of standardized bilberry extract Mirtoselect® and French maritime pine bark extract Pycnogenol®, lowers high intraocular pressure (IOP), which significantly reduces the likelihood of developing glaucoma.
- New Study: Mirtogenol(TM) Lowers High Intraocular Hypertension
New research published in the July issue of Molecular Vision demonstrates that natural supplement Mirtogenol(TM), a combination of standardized bilberry extract Mirtoselect® and French maritime pine bark extract Pycnogenol®, lowers high intraocular pressure (IOP), which significantly reduces the likelihood of developing glaucoma.
- The Reduction Of Eye Fatigue Improves Vision In Older Subjects
a current study performed at the Kajita Clinic in Tokyo, Japan and published in March, 2009 has shown significant improvement in the ability to focus on nearby objects in older subjects (mean age of 53.9 ± 5.1 years) with supplementation of the antioxidant, astaxanthin.
- The Reduction Of Eye Fatigue Improves Vision In Older Subjects
a current study performed at the Kajita Clinic in Tokyo, Japan and published in March, 2009 has shown significant improvement in the ability to focus on nearby objects in older subjects (mean age of 53.9 ± 5.1 years) with supplementation of the antioxidant, astaxanthin.
- The Reduction Of Eye Fatigue Improves Vision In Older Subjects
a current study performed at the Kajita Clinic in Tokyo, Japan and published in March, 2009 has shown significant improvement in the ability to focus on nearby objects in older subjects (mean age of 53.9 ± 5.1 years) with supplementation of the antioxidant, astaxanthin.
- The Reduction Of Eye Fatigue Improves Vision In Older Subjects
a current study performed at the Kajita Clinic in Tokyo, Japan and published in March, 2009 has shown significant improvement in the ability to focus on nearby objects in older subjects (mean age of 53.9 ± 5.1 years) with supplementation of the antioxidant, astaxanthin.
- The Reduction Of Eye Fatigue Improves Vision In Older Subjects
a current study performed at the Kajita Clinic in Tokyo, Japan and published in March, 2009 has shown significant improvement in the ability to focus on nearby objects in older subjects (mean age of 53.9 ± 5.1 years) with supplementation of the antioxidant, astaxanthin.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
Mount Laurel, NJ, September 25, 2006 - Fuji Health Science, Inc. (www.fujihealthscience.com), an American subsidiary of Fuji Chemical Industry Co., Ltd., Toyama, Japan announced today the publication of the ninth (9th) clinical study on AstaReal® astaxanthin for the reduction of asthenopia (eye fatigue). The effects of astaxanthin on eyestrain induced by accommodative dysfunction were investigated at the University of Occupational and Environmental Health, Department of Ophthalmology, Japan. Results showed a significant improvement in the astaxanthin supplemented group over the placebo group.
Dr. Vincent Wood, international marketing manager of Fuji Chemical explains, "This study is significant in that it targets prevention of eye fatigue as opposed to treatment.... In addition, this eye study includes a cross-over method which further substantiates astaxanthin’s properties in the prevention and treatment of eye fatigue."
This study is the ninth in a series of human clinicals performed with AstaReal astaxanthin showing efficacy for this growing health concern. In the age of increasing use of screen based equipment and entertainment, asthenopia is experienced by a growing number of people.
According to Charles DePrince, president of Fuji Health Science, "I see this study area for astaxanthin as representing an opportunity for the nutritional industry. Longer term issues such as AMD have been addressed by the industry as a whole, however, the more immediate and chronic issue of eye fatigue has been ignored. I believe the opportunity exists to broaden the eye care market."
Other areas of study on astaxanthin that Fuji is actively pursuing include cardiovascular, weight management, diabetes and metabolic syndrome. Fuji Chemical also holds seven patents for astaxanthin in the human application areas of inflammation, muscle endurance, immune system, dyspepsia, mastitis, fertility and H-pylori, as well as numerous pending patents. Fuji is the leading producer of natural astaxanthin for human nutritional use in the world with state of the art cultivation and production facilities in Maui, Hawaii and Gustavsberg, Sweden. Fuji’s astaxanthin products, AstaReal and AstaCarox, are approved for use in nutritional supplementation in the U.S., Europe, and Japan, as well as other markets worldwide.
- END - |